Chill Brands Group PLC announced on Wednesday that it will cease future development and sales of its non-tobacco nicotine products in the United States in response to increased regulatory restrictions on synthetic nicotine products.
According to a report from Market Watch, this London-listed cannabidiol product company stated that additional product restrictions will result in significant costs for manufacturers and retailers. As a result, they have decided to exit the US market and sell off their remaining synthetic nicotine inventory.
Chill has announced that its "smokeless nicotine" chewing bag product will no longer be released for sale in the US due to new federal regulations on tobacco products. The company says that all of its other products will not be affected. In March, Congress granted the FDA power to regulate synthetic nicotine which included Chill's product. As a result, the company was required to submit a pre-market tobacco product application to legally sell its product, which added a full cost of $400,000 to each flavor variation. After evaluating this requirement, the company determined it was not commercially viable.
Chief Executive Officer, Kaleb Somerton, stated, "This is certainly disappointing, however, this decision will at least prevent us from investing further capital in the project. These resources can now be better allocated towards developing other products and potential revenue streams.
This article is compiled from third-party information and is intended for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is intended solely for industry discussion and research.
Due to limitations in the translator's proficiency, the translated article may not accurately convey the original meaning. Please refer to the original article for accurate information.
Regarding any domestic, Hong Kong-Macao-Taiwan-related, and foreign-related statements and positions, 2FIRSTS remains fully in line with the Chinese government.
The copyrights of the compiled information belong to the original media and authors. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
